Lily Shi

Tolvaptan use in children and adolescents with autosomal dominant polycystic kidney disease: rationale and design of a two-part, randomized, double-blind, placebo-controlled trial

D. Mekahli, M. Cadnapaphornchai, S. Shoaf, 2019, European Journal of Pediatrics.

Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians’ choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study

E. Weiller, C. Correll, R. Baker, 2018, CNS Spectrums.

A Long-Term, Open-Label Study to Evaluate the Safety and Tolerability of Brexpiprazole as Maintenance Treatment in Adults with Schizophrenia

J. Ouyang, A. Forbes, M. Hobart, 2018, The international journal of neuropsychopharmacology.

Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease

M. Litwin, L. Guay-Woodford, D. Mekahli, 2022, Clinical journal of the American Society of Nephrology : CJASN.

Effect of Brexpiprazole on Agitation and Hostility in Patients With Schizophrenia: Post Hoc Analysis of Short- and Long-Term Studies.

L. Citrome, J. Ouyang, R. Baker, 2019, Journal of clinical psychopharmacology.

Efficacy and safety of brexpiprazole in patients with schizophrenia presenting with severe symptoms: Post-hoc analysis of short- and long-term studies

Z. Ismail, Nicola A. Meade, C. Weiss, 2020, Journal of psychopharmacology.

Successful switching of patients with acute schizophrenia from another antipsychotic to brexpiprazole: comparison of clinicians’ choice of cross-titration schedules in a post hoc analysis of a randomized, double-blind, maintenance treatment study

E. Weiller, C. Correll, R. Baker, 2018, CNS Spectrums.